{"title":"男性动脉高血压合并代谢综合征的情感性障碍","authors":"Roman A. Yaskevich, Olga L. Moskalenko","doi":"10.12731/2658-6649-2023-15-1-327-345","DOIUrl":null,"url":null,"abstract":"Purpose. To study the features of affective disorders in men with comorbid chronic coronary heart disease with metabolic syndrome.
 Materials and methods. The study was performed with the participation of 115 male patients diagnosed with chronic coronary heart disease. Metabolic syndrome verification was carried out using the clinical recommendations of the All-Russian Scientific Society of Cardiology (2009). Identification of the presence of anxiety-depressive states and assessment of their severity was carried out using The Hospital Anxiety and Depression scale.
 Results. The study showed that among men with chronic coronary heart disease who have metabolic syndrome, the median averaged anxiety score on the Hospital Anxiety and Depression scale was significantly higher (p=0,041) compared to those without metabolic syndrome. In 17,6% of the examined patients with a combination of chronic coronary heart disease and metabolic syndrome, elevated levels of anxiety were detected. Anxiety disorders of a subclinically pronounced nature were found in 13,7% of the surveyed in this group, and clinically pronounced in 3,9%. Elevated levels of depression were detected in 17,6% of the examined patients with metabolic syndrome. At the same time, depressive disorders of both subclinically expressed and clinically expressed nature were detected with the same frequency: 7,8% vs 7,8%.
 Conclusion. Among patients with chronic coronary heart disease with a comorbid course with metabolic syndrome, the number of people with clinically pronounced anxiety and depression was higher compared to those without metabolic syndrome. In men with chronic coronary heart disease in combination with metabolic syndrome with both increased levels of anxiety and increased levels of depression, 3- and 4-component clusters of metabolic syndrome, including arterial hypertension, abdominal obesity and various dyslipidemias, were more often detected.","PeriodicalId":21854,"journal":{"name":"Siberian Journal of Life Sciences and Agriculture","volume":"204 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"AFFECTIVE DISORDERS IN MEN WITH ARTERIAL HYPERTENSION IN COMBINATION WITH METABOLIC SYNDROME\",\"authors\":\"Roman A. Yaskevich, Olga L. Moskalenko\",\"doi\":\"10.12731/2658-6649-2023-15-1-327-345\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Purpose. To study the features of affective disorders in men with comorbid chronic coronary heart disease with metabolic syndrome.
 Materials and methods. The study was performed with the participation of 115 male patients diagnosed with chronic coronary heart disease. Metabolic syndrome verification was carried out using the clinical recommendations of the All-Russian Scientific Society of Cardiology (2009). Identification of the presence of anxiety-depressive states and assessment of their severity was carried out using The Hospital Anxiety and Depression scale.
 Results. The study showed that among men with chronic coronary heart disease who have metabolic syndrome, the median averaged anxiety score on the Hospital Anxiety and Depression scale was significantly higher (p=0,041) compared to those without metabolic syndrome. In 17,6% of the examined patients with a combination of chronic coronary heart disease and metabolic syndrome, elevated levels of anxiety were detected. Anxiety disorders of a subclinically pronounced nature were found in 13,7% of the surveyed in this group, and clinically pronounced in 3,9%. Elevated levels of depression were detected in 17,6% of the examined patients with metabolic syndrome. At the same time, depressive disorders of both subclinically expressed and clinically expressed nature were detected with the same frequency: 7,8% vs 7,8%.
 Conclusion. Among patients with chronic coronary heart disease with a comorbid course with metabolic syndrome, the number of people with clinically pronounced anxiety and depression was higher compared to those without metabolic syndrome. In men with chronic coronary heart disease in combination with metabolic syndrome with both increased levels of anxiety and increased levels of depression, 3- and 4-component clusters of metabolic syndrome, including arterial hypertension, abdominal obesity and various dyslipidemias, were more often detected.\",\"PeriodicalId\":21854,\"journal\":{\"name\":\"Siberian Journal of Life Sciences and Agriculture\",\"volume\":\"204 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-02-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Siberian Journal of Life Sciences and Agriculture\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.12731/2658-6649-2023-15-1-327-345\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Agricultural and Biological Sciences\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Siberian Journal of Life Sciences and Agriculture","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12731/2658-6649-2023-15-1-327-345","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Agricultural and Biological Sciences","Score":null,"Total":0}
引用次数: 0
摘要
目的。探讨男性慢性冠心病伴代谢综合征患者情感性障碍的特点。
材料和方法。这项研究是在115名诊断为慢性冠心病的男性患者的参与下进行的。代谢综合征验证采用全俄科学心脏病学会(2009)的临床建议进行。使用医院焦虑抑郁量表(the Hospital Anxiety and Depression scale)识别焦虑抑郁状态的存在并评估其严重程度。
结果。研究表明,在患有代谢综合征的慢性冠心病患者中,医院焦虑和抑郁量表的平均焦虑得分中位数明显高于没有代谢综合征的患者(p=0,041)。在17.6%患有慢性冠心病和代谢综合征的患者中,检测到焦虑水平升高。在这组被调查的人中,有13.7%的人有亚临床表现的焦虑障碍,有3.9%的人有临床表现。在接受检查的代谢综合征患者中,有17.6%的人发现抑郁水平升高。同时,亚临床表达性和临床表达性抑郁症的检出率相同,分别为7.8%和7.8%。
结论。在伴有代谢综合征的慢性冠心病患者中,与没有代谢综合征的患者相比,临床表现出焦虑和抑郁的人数更高。在慢性冠心病合并代谢综合征并焦虑和抑郁水平增加的男性中,代谢综合征的3-和4-组分簇,包括动脉高血压、腹部肥胖和各种血脂异常,更常被检测到。
AFFECTIVE DISORDERS IN MEN WITH ARTERIAL HYPERTENSION IN COMBINATION WITH METABOLIC SYNDROME
Purpose. To study the features of affective disorders in men with comorbid chronic coronary heart disease with metabolic syndrome.
Materials and methods. The study was performed with the participation of 115 male patients diagnosed with chronic coronary heart disease. Metabolic syndrome verification was carried out using the clinical recommendations of the All-Russian Scientific Society of Cardiology (2009). Identification of the presence of anxiety-depressive states and assessment of their severity was carried out using The Hospital Anxiety and Depression scale.
Results. The study showed that among men with chronic coronary heart disease who have metabolic syndrome, the median averaged anxiety score on the Hospital Anxiety and Depression scale was significantly higher (p=0,041) compared to those without metabolic syndrome. In 17,6% of the examined patients with a combination of chronic coronary heart disease and metabolic syndrome, elevated levels of anxiety were detected. Anxiety disorders of a subclinically pronounced nature were found in 13,7% of the surveyed in this group, and clinically pronounced in 3,9%. Elevated levels of depression were detected in 17,6% of the examined patients with metabolic syndrome. At the same time, depressive disorders of both subclinically expressed and clinically expressed nature were detected with the same frequency: 7,8% vs 7,8%.
Conclusion. Among patients with chronic coronary heart disease with a comorbid course with metabolic syndrome, the number of people with clinically pronounced anxiety and depression was higher compared to those without metabolic syndrome. In men with chronic coronary heart disease in combination with metabolic syndrome with both increased levels of anxiety and increased levels of depression, 3- and 4-component clusters of metabolic syndrome, including arterial hypertension, abdominal obesity and various dyslipidemias, were more often detected.